I. J. Christensen

发表

Permeability of commercial solvents through living human skin.

C. Hansen, C. Ursin, J. V. Van Dyk, 1995, American Industrial Hygiene Association journal.

Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.

C. Holst-Hansen, Thomas Leth Frandsen, I. J. Christensen, 2001, Cancer research.

Growth pattern of colorectal liver metastasis as a marker of recurrence risk

I. Christensen, B. Vainer, P. Vermeulen, 2015, Clinical & Experimental Metastasis.

Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer

H. Harling, S. Laurberg, I. Christensen, 2008, The British journal of surgery.

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

B. Rasmussen, G. Freiss, S. Khalaf, 1989, Cancer research.

Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group.

I. Christensen, J. Eickhoff, P. Klarskov, 1997, The Journal of urology.

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.

I. Christensen, M. Sehested, P. B. Jensen, 1997, British Journal of Cancer.

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis

E. Langholz, L. Riis, M. Malham, 2023, Scientific reports.

Lactational competence and involution of the mouse mammary gland require plasminogen.

B. Nielsen, Z. Werb, I. Christensen, 2000, Development.

The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.

N. Brünner, I. Christensen, P. Briand, 2000, Cancer research.

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.

H. Nielsen, I. Christensen, M. Blankenstein, 2008, The International journal of biological markers.

Impact of elective resection on plasma TIMP‐1 levels in patients with colon cancer

H. Nielsen, N. Brünner, I. Christensen, 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.

H. Nielsen, N. Brünner, H. Lilja, 2002, Clinical chemistry.

A randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery

H. Nielsen, I. Christensen, K. Levic, 2014, Techniques in Coloproctology.

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

I. Christensen, B. Rasmussen, B. Pau, 1989, Cancer research.

Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients

H. Nielsen, N. Brünner, W. Stetler-Stevenson, 2005, Scandinavian journal of immunology.

Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.

I. Christensen, C. Høgdall, L. Lundvall, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy

G. Daugaard, M. Mau-Sørensen, A. Nørgaard, 2018, Transfusion medicine.

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer.

H. Nielsen, N. Brünner, T. Ørntoft, 2006, The International journal of biological markers.

Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy

T. Urup, A. Rykkje, I. J. Christensen, 2024, Scientific reports.

Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms

S. Thiel, R. Steffensen, I. Christensen, 2007, Genes and Immunity.

Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats

P. Iversen, J. Larsen, R. Hodgkiss, 2000, Cell proliferation.

Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

I. Svane, S. Hadrup, J. Skjøth-Rasmussen, 2024, Cancer immunology research.

Pretransplant C‐reactive Protein as A Prognostic Marker in Allogeneic Stem Cell Transplantation

I. Christensen, H. Sengeløv, C. Heilmann, 2014, Scandinavian journal of immunology.

Delayed dental maturity in dentitions with agenesis of mandibular second premolars.

I. Christensen, I. Kjaer, S. Daugaard, 2010, Orthodontics & craniofacial research.

A precise and efficient stereological method for determining murine lung metastasis volumes.

B. Nielsen, I. Christensen, L. Lund, 2001, The American journal of pathology.